Weinstein Brielle, Kumar Ambuj, Smith Paul, Dayicioglu Deniz
From the Division of Plastic and Reconstructive Surgery, Department of Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL.
Ann Plast Surg. 2018 Jun;80(6S Suppl 6):S377-S380. doi: 10.1097/SAP.0000000000001322.
Tissue expander and implant remains the most common technique for breast reconstruction. A controversial topic within this method is routine use of acellular dermal matrix (ADM). Acellular dermal matrices have increased risks of infection, seroma, hematoma, skin flap necrosis, and total complications.
After an institutional review board approval, a retrospective chart review was conducted of 756 tissue expander with implant cases from November 2010 to November 2016 at Moffitt Cancer Center with 2 breast reconstruction surgeons. Patients were grouped in 2 groups: tissue expander alone reconstruction (TE) and tissue expander with ADM (TE + ADM). Complications were defined by return visits to the operating room for irrigation and debridement as well as for subsequent tissue expander placement.
There were 703 patients in the TE group and 53 in the TE + ADM group. Patients undergoing TE + ADM reconstruction were 3 times more likely to experience return to operating room compared with patients undergoing TE alone (7.5% vs 2.4%). Patients were significantly more likely to undergo 3 or more subsequent tissue expander placement procedures with TE + ADM (54.7%) compared with TE alone (4.8%) (P < 0.0001).
Although ADM may be appropriate for specific patients, its use in tissue expander breast reconstruction should be judiciously selected, because there is an observed increase in complications needing return to the operating room.
组织扩张器和植入物仍然是乳房重建最常用的技术。该方法中一个有争议的话题是脱细胞真皮基质(ADM)的常规使用。脱细胞真皮基质会增加感染、血清肿、血肿、皮瓣坏死及总体并发症的风险。
经机构审查委员会批准,对2010年11月至2016年11月在莫菲特癌症中心由2名乳房重建外科医生进行的756例组织扩张器植入病例进行回顾性图表审查。患者分为两组:单纯组织扩张器重建(TE)组和使用ADM的组织扩张器重建(TE + ADM)组。并发症定义为因冲洗和清创以及随后的组织扩张器植入而返回手术室。
TE组有703例患者,TE + ADM组有53例患者。与单纯接受TE重建的患者相比,接受TE + ADM重建的患者返回手术室的可能性高3倍(7.5%对2.4%)。与单纯TE组(4.8%)相比,TE + ADM组患者更有可能接受3次或更多次后续组织扩张器植入手术(54.7%)(P < 0.0001)。
虽然ADM可能适用于特定患者,但应谨慎选择其在组织扩张器乳房重建中的使用,因为观察到需要返回手术室的并发症有所增加。